Showing results (31-40 of 164) with videos related to
Sort By:
Pageof 17
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
High-Cost Patients and Preventable Spending: A Population-Based StudyClaire de Oliveira, Joyce Cheng, Kelvin Chan, et al.Hospital Topics|February 23, 2013
Does warfarin use impact hospital length of stay? A retrospective study looking at patients treated for atrial fibrillationNicole Mittmann, Blair Henry, Shahryar Murshed, et al.The Journal of Spinal Cord Medicine|June 21, 2018
The lifetime cost of spinal cord injury in Ontario, Canada: A population-based study from the perspective of the public health care payerBrian Chun-Fai Chan, Suzanne M Cadarette, Walter P Wodchis, et al.International Wound Journal|June 22, 2012
The average cost of pressure ulcer management in a community dwelling spinal cord injury populationBrian C Chan, Natasha Nanwa, Nicole Mittmann, et al.American Journal of Clinical Dermatology|December 8, 2011
Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series studyNicole Mittmann, Sandra R Knowles, Marika Koo, et al.Drug Safety|May 15, 2004
Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysisNicole Mittmann, Sandra R Knowles, Manuel Gomez, et al.Journal of Cutaneous Medicine and Surgery|March 17, 2015
Cost and Resource Use of Pemphigus and Pemphigoid Disorders Pre- and Post-RituximabKara Heelan, Shazia Hassan, Grace Bannon, et al.American Journal of Obstetrics and Gynecology|December 3, 2015
Phase-specific healthcare costs of cervical cancer: estimates from a population-based studyNing Liu, Nicole Mittmann, Peter C Coyte, et al.Journal of Medical Screening|July 28, 2018
The effect of mammography screening regimen on incidence-based breast cancer mortalityMartin J Yaffe, Nicole Mittmann, Oguzhan Alagoz, et al.CMAJ Open|August 22, 2019
Demographic characteristics and cost of treatment among oncology patients in a publicly funded system, the Ontario Trillium Drug Program: a retrospective cohort studyStephanie Y Cheng, Farah E Saxena, Soo Jin Seung, et al.Pageof 17